{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:14:28Z","timestamp":1773285268010,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd010449","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,2,4]],"date-time":"2014-02-04T00:00:00Z","timestamp":1391472000000}}],"reference-count":38,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010449.pub2","type":"journal-article","created":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T16:45:58Z","timestamp":1394124358000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Exenterative surgery for recurrent gynaecological malignancies"],"prefix":"10.1002","volume":"2016","author":[{"given":"Christine","family":"Ang","sequence":"first","affiliation":[{"name":"Northern Gynaecological Oncology Centre; Queen Elizabeth Hospital Sheriff Hill Gateshead UK NE9 6SX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Bryant","sequence":"additional","affiliation":[{"name":"Newcastle University; Institute of Health & Society; Medical School New Build Richardson Road Newcastle upon Tyne UK NE2 4AX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desmond PJ","family":"Barton","sequence":"additional","affiliation":[{"name":"Royal Marsden Hospital; Division of Gynaecological Oncology; Fulham Road London UK SW3 6JJ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Pomel","sequence":"additional","affiliation":[{"name":"Jean Perrin Comprehensive Cancer Centre of Auvergne; Surgical Oncology; Clermont-Ferrand France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raj","family":"Naik","sequence":"additional","affiliation":[{"name":"Northern Gynaecological Oncology Centre; Queen Elizabeth Hospital Sheriff Hill Gateshead UK NE9 6SX"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,2,4]]},"reference":[{"key":"10.1002\/14651858.CD010449.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1046\/j.1365-2168.1999.01139.x","article-title":"Phase II trial of radical surgery for locally advanced pelvic neoplasia","volume":"86","author":"Bramhall","year":"1999","journal-title":"British Journal of Surgery"},{"key":"10.1002\/14651858.CD010449.pub2-BIB0002|cit2","unstructured":"Hathout L Despres P Nguyen TV Provencher D Drouin P Gauthier P Salvage treatment of central pelvic recurrence of uterine cervical cancer Proceedings from ESTRO 29 2010 S306"},{"key":"10.1002\/14651858.CD010449.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijgo.2004.12.020","article-title":"Clinical aspects and prognosis of pelvic recurrence of cervical carcinoma","volume":"89","author":"Kasamatsu","year":"2005","journal-title":"International Journal of Gynecology & Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD010449.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0306-3356(21)00101-1","article-title":"Surgical management of advanced and recurrent cervical carcinoma: the place of pelvic exenteration","volume":"12","author":"Monaghan","year":"1985","journal-title":"Clinical Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD010449.pub2-BIB0005|cit5","first-page":"62","article-title":"The assessment and surgical management of recurrent pelvic cancer of the female genitalia","volume":"80 Suppl 1","author":"Monaghan","year":"1997","journal-title":"British Journal of Urology"},{"key":"10.1002\/14651858.CD010449.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/jso.20847","article-title":"The role of pelvic exenteration and reconstruction for treatment of advanced or recurrent gynecologic malignancies: analysis of risk factors predicting recurrence and survival","volume":"96","author":"Park","year":"2007","journal-title":"Journal of Surgical Oncology"},{"key":"10.1002\/14651858.CD010449.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.suronc.2011.12.008","article-title":"Management of recurrent cervical cancer: a review of the literature","volume":"21","author":"Peiretti","year":"2012","journal-title":"Surgical Oncology"},{"key":"10.1002\/14651858.CD010449.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1471-0528.1994.tb13156.x","article-title":"Pelvic exenteration: a review of the Gateshead experience 1974-1992","volume":"101","author":"Robertson","year":"1994","journal-title":"BJOG"},{"key":"10.1002\/14651858.CD010449.pub2-BIB0009|cit9","first-page":"Art.No.: CD0087","article-title":"Surgical cytoreduction for recurrent epithelial ovarian cancer","volume":"Issue 10","author":"Al Rawahi","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD010449.pub2-BIB0010|cit10","unstructured":"American Cancer Society When cancer comes back: cancer recurrence 2013 http:\/\/www.cancer.org\/acs\/groups\/cid\/documents\/webcontent\/002947-pdf.pdf"},{"key":"10.1002\/14651858.CD010449.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/1097-0142(194807)1:2<177::AID-CNCR2820010203>3.0.CO;2-A","article-title":"Complete excision of pelvic viscera for advanced carcinoma","volume":"1","author":"Brunschwig","year":"1948","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD010449.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0002-9378(73)90047-1","article-title":"Omental sling for management of the pelvic floor following exenteration","volume":"117","author":"Buchsbaum","year":"1973","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD010449.pub2-BIB0013|cit13","unstructured":"Cancer Registrations in Northern Ireland Northern Ireland Cancer Registry 2011"},{"key":"10.1002\/14651858.CD010449.pub2-BIB0014|cit14","unstructured":"Cancer Registrations in Wales Welsh Cancer Intelligence and Surveillance Unit 2010"},{"key":"10.1002\/14651858.CD010449.pub2-BIB0015|cit15","doi-asserted-by":"crossref","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 The Cochrane Collaboration 2008 www.cochrane handbook.org","DOI":"10.1002\/9780470712184"},{"key":"10.1002\/14651858.CD010449.pub2-BIB0016|cit16","unstructured":"CTCAE Common Terminology Criteria for Adverse Events, v 3.0 (CTCAE), August 9, 2006 http:\/\/ctep.cancer.gov\/forms\/CTCAEv3.pdf. Accessed Feb 13."},{"key":"10.1002\/14651858.CD010449.pub2-BIB0017|cit17","volume-title":"Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis.\u00a0In: Egger M, Davey Smith G, Altman DG, editor(s).\u00a0Systematic Reviews in Health Care: Meta-Analysis in Context","author":"Deeks","year":"2001"},{"issue":"3","key":"10.1002\/14651858.CD010449.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"3","key":"10.1002\/14651858.CD010449.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0090-8258(91)90308-R","article-title":"Early stage I adenocarcinoma of the uterine cervix: treatment results in patients with tumors less than or equal to 4 cm in diameter","volume":"41","author":"Eifel","year":"1991","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD010449.pub2-BIB0020|cit20","unstructured":"Ferlay J Shin HR Bray F Forman D Mathers C Parkin DM Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer, 2010. http:\/\/globocan.iarc.fr GLOBOCAN 2008. Accessed February 2012."},{"issue":"3","key":"10.1002\/14651858.CD010449.pub2-BIB0021|cit21","first-page":"DOI: 10.1002\/14","article-title":"Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix","volume":"20","author":"Green","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7414","key":"10.1002\/14651858.CD010449.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010449.pub2-BIB0023|cit23","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. www.cochrane-handbook.org"},{"issue":"10","key":"10.1002\/14651858.CD010449.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1470-2045(06)70903-2","article-title":"Pelvic exenteration for gynaecological tumours: achievements and unanswered questions","volume":"7","author":"H\u00f6ckel","year":"2006","journal-title":"Lancet Oncology"},{"issue":"2 Suppl","key":"10.1002\/14651858.CD010449.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.ygyno.2008.07.022","article-title":"Laterally extended endopelvic resection (LEER)-principles and practice","volume":"111","author":"H\u00f6ckel","year":"2008","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD010449.pub2-BIB0026|cit26","unstructured":"\u00a0ISD Scotland Online Cancer Registrations in Scotland 2011 http:\/\/www.isdscotland.org\/Health-Topics\/Cancer\/Cancer-Statistics\/Female-Genital-Organ\/#vulva. Accessed February 2013"},{"issue":"3","key":"10.1002\/14651858.CD010449.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0090-8258(89)90512-X","article-title":"Pelvic exenteration for recurrent or persistent gynecologic malignancies: a 10-year review of the Memorial Sloan-Kettering Cancer Center experience (1972-1981)","volume":"33","author":"Lawhead","year":"1989","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD010449.pub2-BIB0028|cit28","unstructured":"Office for National Statistics 2011 Cancer statistics registrations: registrations of cancer diagnosed in 2008, England"},{"key":"10.1002\/14651858.CD010449.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17(24)","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010449.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bpobgyn.2005.10.007","article-title":"Worldwide burden of gynaecological cancer: the size of the problem","volume":"20","author":"Sankaranarayanan","year":"2006","journal-title":"Best Practice & Research Clinical Obstetrics & Gynaecology"},{"issue":"3","key":"10.1002\/14651858.CD010449.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ygyno.2012.03.001","article-title":"Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer","volume":"125","author":"Schmidt","year":"2012","journal-title":"Gynecologic Oncology"},{"issue":"6","key":"10.1002\/14651858.CD010449.pub2-BIB0032|cit32","first-page":"1027","article-title":"Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix","volume":"73","author":"Shingleton","year":"1989","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD010449.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0090-8258(89)90020-6","article-title":"Pelvic exenteration: factors associated with major surgical morbidity","volume":"35","author":"Soper","year":"1989","journal-title":"Gynecologic Oncology"},{"issue":"4","key":"10.1002\/14651858.CD010449.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/00003081-199012000-00026","article-title":"Pelvic exenteration for recurrent cervical cancer","volume":"33","author":"Stanhope","year":"1990","journal-title":"Clinical Obstetrics and Gynecology"},{"issue":"7","key":"10.1002\/14651858.CD010449.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/0002-9378(75)90908-4","article-title":"Exenterative operations: experience with 198 patients","volume":"121","author":"Symmonds","year":"1975","journal-title":"American Journal of Obstetrics & Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD010449.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1200\/JCO.2001.19.2.364","article-title":"Tamoxifen in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study","volume":"19","author":"Thigpen","year":"2001","journal-title":"Journal of Clinical Oncology"},{"issue":"19","key":"10.1002\/14651858.CD010449.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1200\/JCO.2004.02.088","article-title":"Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study","volume":"22","author":"Thigpen","year":"2004","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD010449.pub2-BIB0038|cit38","unstructured":"World Health Organization World Health Statistics 2008 www.who.int\/whosis\/whostat\/2008\/en\/index.html. Accessed February 2013"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD010449.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T11:20:01Z","timestamp":1690024801000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010449.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecological, Neuro-oncology and Orphan Cancer Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,4]]},"references-count":38,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010449.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,4]]}}}